Integra LifeSciences (IART) Q4 2024 Annual Earnings
IART·Reported February 25, 2025·Before market open
Integra LifeSciences reported Q4 2024 revenue of $442.6M, beat analyst consensus of $411.7M by $30.9M. Diluted EPS came in at $0.97, beat the $0.86 consensus by $0.11.
Revenue
$442.6Mbeat by $30.9M
Consensus: $411.7MDiluted EPS
$0.97beat by $0.11
Consensus: $0.86
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Integra LifeSciences's Q4 2024 earnings report.
Integra LifeSciences (IART) reported Q4 2024 earnings on February 25, 2025 before market open.
Integra LifeSciences reported revenue of $442.6M and diluted EPS of $0.97 for Q4 2024.
Revenue beat the consensus estimate of $411.7M by $30.9M. EPS beat the consensus estimate of $0.86 by $0.11.
You can read the 10-K periodic report (0000917520-25-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.